SC IL-1Ra in SAH - Phase III Trial (SCIL)
NCT03249207
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
612
Enrollment
OTHER
Sponsor class
Conditions
Subarachnoid Hemorrhage
Interventions
DRUG:
IL-1Ra
DRUG:
IL-1Ra Placebo
Sponsor
University of Manchester
Collaborators
[object Object]
[object Object]
[object Object]